Australia's PBS growth is slowest for 15 years, industry told

21 March 2011

New Medicare Australia data shows that expenditure on the Pharmaceutical Benefits Scheme (PBS) is growing more slowly than at any time in the last 15 years, trade group Medicines Australia chairman Will Delaat told an industry conference on the Gold Coast last week.

Mr Delaat used his annual State of the Industry Symposium address at the APP conference to explode the myth that public expenditure on the Pharmaceutical Benefits Scheme is growing too quickly.

“The Commonwealth Treasury’s own forecasts from last year’s Budget suggest the PBS will grow at only 2.1% per annum in real terms over the next four years,” Mr Delaat told the conference.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical